US Stock MarketDetailed Quotes

SNOA Sonoma Pharmaceuticals

Watchlist
  • 2.9100
  • +0.0700+2.46%
Close Nov 21 16:00 ET
  • 2.8511
  • -0.0589-2.02%
Post 17:55 ET
3.90MMarket Cap-2939P/E (TTM)

Sonoma Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Sep 30, 2024
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
128.76%354K
-324.19%-912K
61.02%-2.4M
106.23%152K
-217.24%-1.1M
32.73%-1.23M
85.98%-215K
-44.82%-6.15M
-74.98%-2.44M
-6.75%-348K
Net income from continuing operations
58.89%-610K
19.39%-1.14M
6.13%-4.84M
18.43%-1.07M
55.34%-866K
-45.92%-1.48M
-59.86%-1.42M
-1.28%-5.15M
55.57%-1.31M
-105.40%-1.94M
Operating gains losses
----
----
----
----
----
----
----
99.86%-1K
----
----
Depreciation and amortization
-22.22%35K
-13.33%39K
40.80%176K
20.59%41K
40.63%45K
60.71%45K
45.16%45K
-32.80%125K
-30.61%34K
-13.51%32K
Deferred tax
22.22%66K
35.56%122K
-194.59%-109K
-197.10%-201K
---52K
--54K
325.00%90K
95.54%-37K
--207K
----
Other non cash items
----
-30.38%55K
-6.94%161K
----
----
----
--79K
-22.42%173K
----
----
Change In working capital
777.67%904K
-111.33%-92K
187.72%1.69M
169.81%1.15M
-123.77%-371K
110.36%103K
195.42%812K
-161.64%-1.93M
-150.24%-1.65M
131.26%1.56M
-Change in receivables
-76.63%43K
-346.07%-470K
-5,650.00%-230K
93.23%-9K
-306.23%-596K
311.49%184K
361.64%191K
-100.20%-4K
-106.55%-133K
-46.18%289K
-Change in inventory
-247.98%-256K
-149.57%-114K
--184K
70.99%277K
-274.04%-496K
163.60%173K
231.43%230K
--0
-39.10%162K
166.90%285K
-Change in prepaid assets
720.61%1.08M
170.24%59K
461.76%1.11M
163.90%561K
185.14%499K
-72.30%131K
-10.53%-84K
33.48%-306K
-52.96%-878K
-55.92%175K
-Change in payables and accrued expense
104.81%24K
-6.98%480K
163.34%216K
116.53%98K
-85.13%101K
52.88%-499K
-18.35%516K
-138.66%-341K
-189.71%-593K
534.58%679K
-Change in other current assets
----
----
----
----
-72.60%20K
----
----
----
----
1.39%73K
-Change in other current liabilities
---47K
30.38%-55K
6.94%-161K
21.52%-62K
71.83%-20K
--0
15.96%-79K
22.07%-173K
-2.60%-79K
0.00%-71K
-Change in other working capital
-205.71%-37K
-78.95%8K
152.17%577K
1,335.48%383K
-7.63%121K
131.82%35K
103.47%38K
-204.34%-1.11M
-102.77%-31K
122.03%131K
Cash from discontinued investing activities
Operating cash flow
128.76%354K
-324.19%-912K
61.02%-2.4M
106.23%152K
-217.24%-1.1M
32.73%-1.23M
85.98%-215K
-44.82%-6.15M
-74.98%-2.44M
-6.75%-348K
Investing cash flow
Cash flow from continuing investing activities
-1,200.00%-26K
70.59%-5K
99.22%-2K
121.95%18K
-102.94%-1K
98.93%-2K
26.09%-17K
-160.61%-258K
-34.43%-82K
34K
Net PPE purchase and sale
-1,200.00%-26K
70.59%-5K
93.68%-17K
101.58%3K
96.77%-1K
92.00%-2K
26.09%-17K
-96.35%-269K
-206.45%-190K
-3,000.00%-31K
Net other investing changes
----
----
36.36%15K
----
----
----
----
-71.05%11K
10,700.00%108K
6,400.00%65K
Cash from discontinued investing activities
Investing cash flow
-1,200.00%-26K
70.59%-5K
99.22%-2K
121.95%18K
-102.94%-1K
98.93%-2K
26.09%-17K
-160.61%-258K
-34.43%-82K
--34K
Financing cash flow
Cash flow from continuing financing activities
1,219.38%1.44M
571.11%636K
-32.66%1.68M
-81.55%622K
514.47%1.32M
27.53%-129K
65.12%-135K
-66.35%2.49M
1,418.92%3.37M
-168.68%-318K
Net issuance payments of debt
5.43%-122K
8.46%-119K
46.20%-481K
6.00%-94K
44.10%-128K
40.00%-129K
62.86%-130K
-139.04%-894K
-145.05%-100K
-15.08%-229K
Net common stock issuance
--1.54M
15,060.00%748K
-37.80%1.78M
-88.21%338K
--1.45M
--0
---5K
-62.03%2.87M
--2.87M
--0
Proceeds from stock option exercised by employees
--26K
--7K
----
----
----
--0
--0
----
----
----
Net other financing activities
----
----
-27.57%373K
-37.42%378K
----
----
----
--515K
--604K
----
Cash from discontinued financing activities
Financing cash flow
1,219.38%1.44M
571.11%636K
-32.66%1.68M
-81.55%622K
514.47%1.32M
27.53%-129K
65.12%-135K
-66.35%2.49M
1,418.92%3.37M
-168.68%-318K
Net cash flow
Beginning cash position
-26.95%2.59M
-18.12%3.13M
-48.35%3.82M
-8.66%2.41M
-36.23%2.14M
-36.56%3.54M
-48.35%3.82M
75.26%7.4M
-69.12%2.63M
-60.07%3.35M
Current changes in cash
230.10%1.77M
23.43%-281K
81.54%-724K
-6.71%792K
133.70%213K
37.95%-1.36M
81.11%-367K
-228.60%-3.92M
168.80%849K
-561.31%-632K
Effect of exchange rate changes
-528.89%-283K
-383.52%-258K
-90.72%32K
-120.77%-70K
165.88%56K
-12.50%-45K
-31.58%91K
171.65%345K
233.66%337K
---85K
End cash Position
90.83%4.08M
-26.95%2.59M
-18.12%3.13M
-18.12%3.13M
-8.66%2.41M
-36.23%2.14M
-36.56%3.54M
-48.35%3.82M
-48.35%3.82M
-69.12%2.63M
Free cash flow
126.60%328K
-295.26%-917K
62.39%-2.42M
105.89%155K
-191.56%-1.11M
33.53%-1.23M
85.09%-232K
-46.43%-6.42M
-80.58%-2.63M
-15.90%-379K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Sep 30, 2024(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 128.76%354K-324.19%-912K61.02%-2.4M106.23%152K-217.24%-1.1M32.73%-1.23M85.98%-215K-44.82%-6.15M-74.98%-2.44M-6.75%-348K
Net income from continuing operations 58.89%-610K19.39%-1.14M6.13%-4.84M18.43%-1.07M55.34%-866K-45.92%-1.48M-59.86%-1.42M-1.28%-5.15M55.57%-1.31M-105.40%-1.94M
Operating gains losses ----------------------------99.86%-1K--------
Depreciation and amortization -22.22%35K-13.33%39K40.80%176K20.59%41K40.63%45K60.71%45K45.16%45K-32.80%125K-30.61%34K-13.51%32K
Deferred tax 22.22%66K35.56%122K-194.59%-109K-197.10%-201K---52K--54K325.00%90K95.54%-37K--207K----
Other non cash items -----30.38%55K-6.94%161K--------------79K-22.42%173K--------
Change In working capital 777.67%904K-111.33%-92K187.72%1.69M169.81%1.15M-123.77%-371K110.36%103K195.42%812K-161.64%-1.93M-150.24%-1.65M131.26%1.56M
-Change in receivables -76.63%43K-346.07%-470K-5,650.00%-230K93.23%-9K-306.23%-596K311.49%184K361.64%191K-100.20%-4K-106.55%-133K-46.18%289K
-Change in inventory -247.98%-256K-149.57%-114K--184K70.99%277K-274.04%-496K163.60%173K231.43%230K--0-39.10%162K166.90%285K
-Change in prepaid assets 720.61%1.08M170.24%59K461.76%1.11M163.90%561K185.14%499K-72.30%131K-10.53%-84K33.48%-306K-52.96%-878K-55.92%175K
-Change in payables and accrued expense 104.81%24K-6.98%480K163.34%216K116.53%98K-85.13%101K52.88%-499K-18.35%516K-138.66%-341K-189.71%-593K534.58%679K
-Change in other current assets -----------------72.60%20K----------------1.39%73K
-Change in other current liabilities ---47K30.38%-55K6.94%-161K21.52%-62K71.83%-20K--015.96%-79K22.07%-173K-2.60%-79K0.00%-71K
-Change in other working capital -205.71%-37K-78.95%8K152.17%577K1,335.48%383K-7.63%121K131.82%35K103.47%38K-204.34%-1.11M-102.77%-31K122.03%131K
Cash from discontinued investing activities
Operating cash flow 128.76%354K-324.19%-912K61.02%-2.4M106.23%152K-217.24%-1.1M32.73%-1.23M85.98%-215K-44.82%-6.15M-74.98%-2.44M-6.75%-348K
Investing cash flow
Cash flow from continuing investing activities -1,200.00%-26K70.59%-5K99.22%-2K121.95%18K-102.94%-1K98.93%-2K26.09%-17K-160.61%-258K-34.43%-82K34K
Net PPE purchase and sale -1,200.00%-26K70.59%-5K93.68%-17K101.58%3K96.77%-1K92.00%-2K26.09%-17K-96.35%-269K-206.45%-190K-3,000.00%-31K
Net other investing changes --------36.36%15K-----------------71.05%11K10,700.00%108K6,400.00%65K
Cash from discontinued investing activities
Investing cash flow -1,200.00%-26K70.59%-5K99.22%-2K121.95%18K-102.94%-1K98.93%-2K26.09%-17K-160.61%-258K-34.43%-82K--34K
Financing cash flow
Cash flow from continuing financing activities 1,219.38%1.44M571.11%636K-32.66%1.68M-81.55%622K514.47%1.32M27.53%-129K65.12%-135K-66.35%2.49M1,418.92%3.37M-168.68%-318K
Net issuance payments of debt 5.43%-122K8.46%-119K46.20%-481K6.00%-94K44.10%-128K40.00%-129K62.86%-130K-139.04%-894K-145.05%-100K-15.08%-229K
Net common stock issuance --1.54M15,060.00%748K-37.80%1.78M-88.21%338K--1.45M--0---5K-62.03%2.87M--2.87M--0
Proceeds from stock option exercised by employees --26K--7K--------------0--0------------
Net other financing activities ---------27.57%373K-37.42%378K--------------515K--604K----
Cash from discontinued financing activities
Financing cash flow 1,219.38%1.44M571.11%636K-32.66%1.68M-81.55%622K514.47%1.32M27.53%-129K65.12%-135K-66.35%2.49M1,418.92%3.37M-168.68%-318K
Net cash flow
Beginning cash position -26.95%2.59M-18.12%3.13M-48.35%3.82M-8.66%2.41M-36.23%2.14M-36.56%3.54M-48.35%3.82M75.26%7.4M-69.12%2.63M-60.07%3.35M
Current changes in cash 230.10%1.77M23.43%-281K81.54%-724K-6.71%792K133.70%213K37.95%-1.36M81.11%-367K-228.60%-3.92M168.80%849K-561.31%-632K
Effect of exchange rate changes -528.89%-283K-383.52%-258K-90.72%32K-120.77%-70K165.88%56K-12.50%-45K-31.58%91K171.65%345K233.66%337K---85K
End cash Position 90.83%4.08M-26.95%2.59M-18.12%3.13M-18.12%3.13M-8.66%2.41M-36.23%2.14M-36.56%3.54M-48.35%3.82M-48.35%3.82M-69.12%2.63M
Free cash flow 126.60%328K-295.26%-917K62.39%-2.42M105.89%155K-191.56%-1.11M33.53%-1.23M85.09%-232K-46.43%-6.42M-80.58%-2.63M-15.90%-379K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Cannabis & Hemp
Cannabis & Hemp
Intraday-0.32%